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ABSTRACT 
Background and Aims: Serrated lesions are an important contributor to colorectal cancer 
(CRC), notably in the proximal colon. Findings in the distal colorectum are markers of advanced 
proximal adenomatous neoplasia. However, it is not known whether they affect the odds of 
advanced proximal serrated lesions.  
Methods: We performed a retrospective cross-sectional study of data from 1910 patients (59.3 
± 8.0 years old, 53.8% female) who underwent an average-risk screening colonoscopy, from 
August 2005 through April 2012, at Indiana University Hospital and an associated ambulatory 
surgery center. Colonoscopies were performed by an endoscopist with high rates of detection of 
adenomas and serrated polyps. Tissue samples of all serrated polyps (hyperplastic, sessile 
serrated adenoma/polyp [SSA/P] or traditional serrated adenoma) proximal to the sigmoid 
colon, and  serrated polyps >5 mm in the rectum or sigmoid colon were reviewed by a 
gastrointestinal pathologist and reclassified based on World Health Organization criteria. 
Advanced serrated lesion (ASL) was defined as SSA/P with cytological dysplasia, SSA/P ≥ 10 
mm, or traditional serrated adenoma. Advanced conventional adenomatous neoplasia (ACN) 
was defined as tubular adenoma ≥ 10 mm, villous histology, high-grade dysplasia, or cancer. 
The prevalence of proximal ASL and ACN was calculated based on distal colorectal findings. 
Multivariable logistic regression analysis was performed to determine the age- and sex-adjusted 
odds of advanced proximal adenomatous and serrated lesions. Secondary analyses were 
performed to examine the effect of variable ASL definitions. 
Results: Fifty-two patients had proximal ASL (2.7%) and 99 had proximal ACN (5.2%). Of the 
52 patients with proximal ASL, 27 had no distal polyps (52%). Of the 99 patients with proximal 
ACN, 40 had no distal polyps (40%). Age and type of distal adenomas were significantly 
associated with proximal ACN. There were no significant associations between distal polyp type 
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and proximal ASL. In secondary analyses, distal SSA/Ps (p=0.008), but not distal HPs or 
conventional adenomas were associated with any proximal SSA/P. 
Conclusions: The findings at flexible sigmoidoscopy that traditionally serve as indications for 
colonoscopy (conventional adenomas), are likely to be ineffective for detection of proximal ASL. 
This finding, plus the observation that most patients with proximal ASL have no distal polyps, 
favors screening colonoscopy over sigmoidoscopy, especially in the elderly. The observation 
that non-advanced distal SSA/Ps are associated with any proximal SSA/P warrants further 
study. 
 
Keywords: early detection, colon cancer, colonoscopy  
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Colorectal cancer (CRC) is preventable and is one of few cancers for which there is 
considerable evidence that screening is effective and cost-effective1,2. Colonoscopy allows the 
detection and removal of precursor polyps during the same session and is the final common 
pathway for other screening modalities; these characteristics have contributed to its position as 
the dominant CRC screening modality in the US. However, colonoscopy requires considerable 
human and financial resources3,4, and the need to balance these constraints with effectiveness 
has increased interest in strategies where colonoscopy is used selectively after initial testing 
with one of the other modalities. Sigmoidoscopy is an attractive option because it is more 
straightforward to perform, is less burdensome, and is associated with lower risk for harm than 
colonoscopy. Randomized controlled trials5-7 and meta-analyses8,9 have shown that flexible 
sigmoidoscopy decreases CRC incidence and mortality, supporting its endorsement by major 
guideline organizations1. Sigmoidoscopy effectively decreases distal CRC incidence and 
mortality; however, its effect on right-sided CRC depends on the colonoscopy referral strategy in 
place. The 4 large randomized trials of screening sigmoidoscopy5-7,10 have employed different 
criteria to refer patients to colonoscopy, but all are based on the premise that the risk of 
advanced neoplasia in the proximal colon can be predicted according to findings in the distal 
colon, allowing the adjudication of colonoscopy referrals based on the presence and 
characteristics of polyps found at sigmoidoscopy11. In this context, the term “advanced 
neoplasia” has been used to refer mainly to lesions on the spectrum of the adenoma-carcinoma 
sequence, including invasive cancer and advanced adenomas (size ≥ 10 mm or presence of 
high-grade dysplasia or significant villous components on histology). Indeed, the studies which 
supported this approach12-15 were performed at a time when it was thought that the great 
majority of colon cancers arose from precursor conventional adenomas via the chromosomal 
instability pathway. However, it is now recognized that nearly one-third of CRCs arise through 
the serrated pathway, which is characterized by mutations in the BRAF gene, high levels of 
methylation of promoter CpG islands (CIMP-high), and in which the sessile serrated 
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adenoma/polyp (SSA/P) is the principle precursor lesion 16-18. Serrated lesions can be 
challenging to visualize because of their subtle morphologic characteristics, and are more likely 
to be overlooked than conventional adenomas19,20.  These features likely account for the fact 
that the serrated pathway is a disproportionate contributor to interval CRC (CRC diagnosed 
relatively soon after colonoscopy). Cancers associated with the serrated pathway tend to occur 
in the proximal colon and their molecular signature overlaps significantly with interval CRC21-23.   
The study of serrated lesions has been complicated by evolving definitions and nomenclature, 
leading to significant inter-observer variability in the histologic differentiation of subtypes of 
serrated polyps, notably between SSA/P and hyperplastic polyps. The World Health 
Organization (WHO) has recently updated the classification of serrated colorectal lesions 18. 
 While it is recognized that distal colorectal adenomas  are a marker of advanced 
proximal conventional adenomatous neoplasia, it is not known whether the same applies to 
important proximal serrated lesions, specifically those higher-risk serrated lesions which warrant 
more intensive surveillance16,24. This issue is of relevance for CRC screening strategies which 
employ sigmoidoscopy as the initial test and refer patients to colonoscopy based on distal 
findings. Such approaches are based on the assumption that the relevant target proximal colon 
lesions are predominantly adenoma-based, an assumption which does not take into account 
serrated lesions and their significant contribution to the pathogenesis of CRC. To help 
understand whether distal colorectal findings are predictive of advanced serrated lesions in the 
proximal colon, we analyzed data from a large group of average-risk patients who had 
undergone screening colonoscopy by an endoscopist with high detection rates of adenomatous 
and serrated polyps, combined with review of histology by an expert pathologist with specific 
interest in serrated polyps, using the WHO consensus guidelines.  
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METHODS 
This was a cross-sectional study conducted at Indiana University Hospital and an 
associated ambulatory surgery center in Indianapolis, Indiana.  The study was approved by the 
Institutional Review Board of Indiana University Health.  We reviewed a prospectively updated 
electronic database for all patients ≥ 50 years old who underwent an average-risk screening 
colonoscopy between August 2005 and April 2012 by an endoscopist with documented high 
adenoma and serrated polyp detection rates (DKR).  The colonoscopy database contains 
information regarding patient demographics, and number, location, size, shape and the 
histopathology of resected polyps.  Patients who underwent colonoscopy for any indication 
other than screening (diagnostic colonoscopy for evaluation of symptoms or occult bleeding, 
history of inflammatory bowel disease, family history of familial adenomatous polyposis, 
surveillance colonoscopy after polypectomy or CRC resection), were excluded.  The proximal 
colon was defined as cecum, ascending colon, and transverse colon, and the distal colon as 
splenic flexure, descending colon, sigmoid colon, and rectum.   During the interval in which the 
colonoscopies were performed, the study colonoscopist did not systematically remove all 
diminutive hyperplastic appearing lesions from the rectosigmoid colon, particularly in patients 
who had  numerous such lesions. 
For the pathology review, we identified all serrated polyps proximal to the sigmoid colon, 
and serrated polyps >5mm in the rectum or sigmoid colon. Rectosigmoid serrated polyps ≤ 5 
mm are overwhelmingly hyperplastic and are not considered to have malignant potential 16,24. 
Pathology slides were retrieved and reviewed by an experienced GI pathologist (DCS) who was 
blinded to polyp anatomic location, shape, size, and initial histopathological diagnosis.  Serrated 
polyps were categorized using the WHO classification18 into hyperplastic polyps (HP), sessile 
serrated polyps without (SSA/P) and with cytological dysplasia (SSA/P-CD), and traditional 
serrated adenomas (TSA).  SSA/P was diagnosed if a serrated lesion had at least one crypt 
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showing evidence of abnormal proliferation and maturation as evidenced by mature cells at the 
base of the crypt associated with a dilated, boot or anchor shape and/or excess crypt serration 
near the base. A diagnosis of HP required that all crypts show normal maturation toward the 
surface with a normally located basal proliferative zone. For the primary analysis, we targeted 
serrated lesions which are considered to be at higher risk for progression to cancer, warranting 
colonoscopic surveillance intervals similar to those of advanced conventional adenomas16,24. 
We refer to these lesions as “advanced serrated lesions” (ASL), grouping SSA/P-CD, SSA/P ≥ 
10 mm, or TSA. We performed a secondary analysis to determine the odds of any proximal 
SSA/P (regardless of size or presence of cytological dysplasia) in patients with distal colorectal 
polyps, compared to patients with no distal polyps. Advanced conventional adenomatous 
neoplasia (ACN) was defined as tubular adenoma (TA) ≥ 10 mm, villous histology, high-grade 
dysplasia, or cancer. Patients were divided into six groups based on their most advanced  distal 
colon finding in the following order - ACN, ASL, non-advanced TA,  SSA/P<10 mm, HP, and no 
polyps. There were no patients with synchronous distal ASL and ACN.   
Statistical analysis 
Descriptive statistics were used to characterize patient demographic features, and to 
determine the prevalence of proximal and distal colon polyps stratified by patient sex. The 
number of patients in whom the most advanced lesion was ACN, and the number of patients in 
whom the most advanced lesion was ASL, were determined. The prevalence of proximal ASL 
and ACN based on distal colorectal findings was calculated. Multivariable logistic-regression 
analysis was performed to determine the age- and sex-adjusted odds of advanced proximal 
adenomatous and serrated lesions, with patients without distal polyps as the reference group. 
Based on the overall sample size of 1910 patients, we determined that the study had 80% 
power to detect an odds ratio of 2.5 for distal polyp as a predictor of ASL or ACN, using a 
logistic regression model with age and sex as covariates. 
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RESULTS 
 The study cohort consisted of 1910 average-risk patients who underwent a screening 
colonoscopy between August 2005 and April 2012. Most patients (1675/1910, 87.7%) had no 
recorded family history of CRC. In the remaining 235, 212 (11.1%) had a first degree relative 
and 23 (1.2%) had a distant relative with CRC. The mean age was 59.3 ± 8.0 years, and 53.8% 
were female. The number of patients with at least one conventional adenoma was 914 (47.8%), 
and the number of patients with at least one serrated lesion (includes HP, SSA/P, and TSA) was 
688 (36.0%). The corresponding detection rates for advanced conventional adenoma and 
advanced serrated lesions were 7.4% and 3.0%, respectively. Overall, distal, and proximal 
colon findings and patient characteristics are shown in Table 1. Five cancers were diagnosed, 3 
in the proximal colon and 2 in the distal colon. There were 52 patients (2.8%) with proximal ASL, 
and 99 (5.1%) with proximal ACN (one patient had both proximal ASL and ACN).  Table 2 lists 
the subcategories of serrated lesions in patients with proximal and distal ASL. Among the 99 
patients with proximal ACN, 61 had at least one TA ≥ 10 mm, 40 had at least one adenoma with 
villous histology, 9 had at least one adenoma with high-grade dysplasia, and 3 had invasive 
cancer.    
Of 52 patients with proximal ASL, 27 (52%) had no distal polyps removed; of 99 patients 
with proximal ACN, 40 (40%) had no distal polyps. The age- and sex- adjusted odds of 
advanced proximal adenomatous and serrated lesions according to distal findings are detailed 
in Table 3. Age and type of distal neoplasia (except non-advanced serrated lesions) were 
associated with proximal ACN. Conversely, only patient age was significantly associated with 
proximal ASL.  There were no significant associations between distal polyps and proximal 
ASL.In secondary analyses (Table 4), presence of a distal SSA/P was the lone factor 
associated with a proximal SSA/P. There were no significant associations with either age or 
gender.  
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DISCUSSION 
 In this study, average-risk patients 50 years of age or older with distal colorectal polyps 
were no more likely to harbor advanced serrated lesions in the proximal colon than patients 
without distal colorectal polyps. In addition, more than half of patients with advanced proximal 
serrated lesions had no polyps in the distal colon. 
Our findings extend and update those studies which addressed similar questions, with 
focus on proximal advanced conventional adenomas. Imperiale et al12 reported increased risk of 
proximal advanced adenomatous neoplasia with increasing age, male sex, presence of distal 
hyperplastic polyps, distal tubular adenomas, and distal advanced polyps. An updated and 
expanded analysis of 10,124 patients aged 50 years or older who underwent colonoscopy found 
that age, male sex, and distal adenomas (but not distal hyperplastic polyps) were associated 
with increased risk of proximal advanced adenomatous neoplasia25. Consistent with these 
findings and reports by Levin et al.14, Schoen et al.15, and Wallace et al.13, we found similar 
relationships between advanced proximal adenomatous neoplasia, and patient age and distal 
colorectal findings. Additionally, 40% of patients with proximal ACN in our cohort had no distal 
colorectal findings, which is comparable to previous reports12. However, previous studies did not 
evaluate the association with proximal advanced serrated lesions.  We found only patient age to 
be significantly associated with proximal ASL, while sex and type of distal colorectal neoplasia 
were not. The proportion of patients with proximal ASL and no distal colorectal polyps was 52%, 
exceeding the proportion of patients with proximal ACN and no distal colorectal polyps. 
These findings are relevant for CRC screening strategies which employ sigmoidoscopy 
as a “gateway” test, and triage patients to colonoscopy based on findings at sigmoidoscopy. 
Distal colorectal findings are associated with the risk of proximal advanced adenomatous 
neoplasia and can be used to tailor screening recommendations and colonoscopy referrals 
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based on evidence-based estimates of the risk of proximal ACN11. However, the observation 
that patients with distal colorectal polyps are no more likely to harbor advanced serrated lesions 
in the proximal colon than patients without distal colorectal polyps is concerning. For example, a 
patient with no polyps at sigmoidoscopy who is not referred for a follow-up colonoscopy based 
exclusively on the estimated risk of advanced ACN, could be harboring significant serrated 
lesions in the proximal colon which would go undetected. The implications of the lack of 
association between distal polyps and proximal ASL risk on the relative effectiveness of 
endoscopic screening strategies are not clear, but may be substantial given the disproportionate 
contribution of the serrated pathway to proximal and interval CRC. The observation that 
increasing age was associated with the risk of proximal ASL warrants additional comment. 
Epidemiologic studies have shown a rightward shift in the distribution of CRC which may be 
related to population aging, and proximal colon cancer is associated with molecular features 
which increase with age and are linked to the serrated pathway (such as methylation and 
microsatellite instability)26,27. Thus, screening colonoscopy may be more appropriate than a 
sigmoidoscopy-first approach in older age groups from the standpoint of detection of advanced 
proximal serrated lesions. Previous work has shown that tailoring CRC screening by quantifying 
the risk of proximal ACN is feasible, and allows the identification of low risk groups (such as 
younger women) who could undergo sigmoidoscopy instead of colonoscopy25. Our study 
sample size did not allow us to conduct similar subgroup analyses. Future studies with larger 
sample sizes should incorporate advanced serrated lesions as a relevant CRC prevention 
target, as this would help further refine current tailoring and risk-stratification strategies, notably 
by identifying patient groups at lower risk for proximal ASL. 
An important feature of our study is the combination of the endoscopic findings of 
colonoscopies performed by a high level detector, with a review of serrated polyps by an 
experienced pathologist using the most recent consensus guidelines. This approach is 
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advantageous for 2 main reasons: First, previous studies reporting prevalence rates of serrated 
lesions in fact reflected the mean detection rates of endoscopists with highly variable detection 
of serrated lesions. Restricting the analysis to a single high-level detector allows the derivation 
of more precise estimates of the relative risks of proximal advanced serrated and adenomatous 
neoplasms based on distal colorectal findings in the same cohort of average-risk patients. 
Second, the histopathologic review of serrated polyps by a single experienced pathologist using 
the most recent WHO consensus guidelines overcomes the issue of variable pathological 
criteria to define SSA/P.   
Our study has limitations which require additional discussion. First, the definition we 
used for advanced serrated lesions is empiric, and is based on consensus guidelines which 
have identified SSA/P with cytological dysplasia, SSA/P ≥ 10 mm, and TSA as equivalent to 
high-risk conventional adenomas which require more intensive post-polypectomy surveillance24. 
The evidence supporting the concept of advanced serrated lesions is less robust than that for 
advanced conventional adenomatous neoplasia, and awaits further data from well-designed 
longitudinal studies.  However, using proximal SSA/P regardless of size or presence of 
cytological dysplasia as the relevant target lesion, also showed no significant association 
between distal findings and proximal SSA/P, with the exception of distal SSA/P group. In this 
regard, the study colonoscopist did not systematically remove all diminutive hyperplastic 
appearing polyps from the rectosigmoid colon.  Thus, we could have missed a significant 
association between distal colon hyperplastic and proximal ASL, or between distal hyperplastic 
polyps and any proximal SSA/P, or between distal SSA/P and proximal serrated endpoints, and 
any missed associations of distal and proximal serrated polyps could have resulted from either 
an insufficient sample size or incomplete clearing of distal colon hyperplastic appearing polyps.  
We recommend additional study of the association of distal colon and proximal serrated lesions. 
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Second, although the overall sample size was large, the number of  proximal ASL and 
ACN “events” was relatively small, precluding certain subgroup analyses; for example, we could 
not determine the odds of proximal ACN or ASL for the subgroup with distal ASL with precision, 
because the latter included only 7 patients. However, we do not believe that the proximal ASL 
prevalence in our study to be a limitation: the proximal ACN prevalence rates are comparable to 
those reported in other similar studies 12, and our proximal ASL rates are thus likely more 
reflective of the actual prevalence of these lesions in average-risk cohorts.    
Third, as with previous studies, our study’s cross-sectional design and the database on 
which it is based limited our ability to account for relevant clinical information such as body-
mass index, tobacco use, and use of NSAIDs, which may influence individual patients’ risk for 
CRC. Finally, distal colorectal findings at sigmoidoscopy were estimated based on findings at 
colonoscopy. The depth of insertion at sigmoidoscopy may vary in clinical practice; however, we 
considered sigmoidoscopy to be complete and the splenic flexure reached in all instances, an 
assumption which is similar to previous studies.        
In summary, we found that distal colon adenomas, which are the clinically accepted 
indicators for colonoscopy when detected at sigmoidoscopy, were not associated with advanced 
proximal colon serrated lesions. A policy of referral for colonoscopy only for distal colon 
conventional adenomas detected by screening flexible sigmoidoscopy will likely fail to detect 
important proximal serrated lesions. Further, more than half of patients with advanced proximal 
serrated lesions had no polyps in the distal colon.  Taken together, to the extent that detection 
of proximal advanced serrated lesions is important to colon cancer prevention, our findings favor 
screening colonoscopy over sigmoidoscopy, especially with increasing age.  Distal colon non-
advanced serrated lesions as a class were associated with any proximal colon SSA/P.  This 
suggests that distal colon hyperplastic polyps (or distal serrated lesions collectively), traditionally 
considered to have no importance when detected during screening flexible sigmoidoscopy, may 
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be a signal for proximal colon SSA/P.  Additional evaluation of this potentially important 
association, to determine which (if any) subgroups of distal serrated lesions are associated with 
proximal serrated findings warrants further evaluation.  
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Table 1 Distribution of colon findings according to the most advanced lesion  
Most advanced finding Proximal Colon Distal Colon Anywhere in the colon 
 N (%) Age 
(SD) 
Sex, 
male 
(%) 
N (%) Age 
(SD) 
Sex, 
male 
(%) 
N (%) Age 
(SD) 
Sex, 
male 
(%) 
No polyps 956 
(50.1) 
57.9 
(7.2) 
390 
(40.8) 
1134 
(59.4) 
59.1 
(7.8) 
494 
(43.6) 
646 
(33.8) 
58.1 
(7.3) 
253 
(39.2) 
HP   125 
(6.5) 
58.3 
(7.3) 
51 
(40.8) 
330 
(17.3) 
58.4 
(7.6) 
145 
(43.9) 
264 
(13.8) 
57.3 
(6.8) 
103 (39) 
SSA/P <10mm with or without 
HP 
55 (2.9) 57.2 
(7.3) 
23 
(41.8) 
16 
(0.8) 
58.6 
(7.9) 
8 (50) 60 
(3.1) 
57.1 
(7.5) 
26 
(43.3) 
Non-advanced adenoma with 
or without non-advanced 
serrated (SSA/P<10mm+HP) 
neoplasia 
624 
(32.7) 
60.9 
(8.1) 
344 
(55.1) 
362 
(19) 
60.7 
(8.5) 
200 
(55.2) 
746 
(39.1) 
60.4 
(8.1) 
403 (54) 
ASL (SSA/P>=10,SSA/P-CD,TSA)  51 (2.7) 61.8 
(9.1) 
18 
(35.3) 
7 (0.4) 60 
(9.6) 
5 
(71.4) 
53 
(2.8) 
61.5 
(9.2) 
21 
(39.6) 
ACN  98 (5.1) 63.8 
(9.8) 
56 
(57.1) 
61 
(3.2) 
59.7 
(7.9) 
31 
(50.8) 
136 
(7.1) 
62.2 
(9.5) 
75 
(55.1) 
ASL+ACN 1 (0.1) 68 1 (100)    5 (0.3) 62 
(6.9) 
2 (40) 
ACN – Advanced conventional neoplasia 
ASL – Advanced serrated lesion 
HP – Hyperplastic polyp 
SSA/P – Sessile serrated adenoma/polyp 
SSA/P-CD – Sessile serrated adenoma/polyp with cytological dysplasia 
TSA – Traditional serrated adenoma 
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Table 2 Subcategories of advanced serrated lesions 
52 patients with proximal ASL(s) 
(only proximal lesions) 
34 patients had 1 SSA/P>=10mm each 
1 patient had 1 SSA/P-CD>=10mm 
7 patients had 1 SSA/P-CD each 
1 patient had 1 TSA-CD  
1 patient had 2 SSA/P-CDs 
4 patients had 2 SSA/Ps each greater than 10mm 
1 patient had 1 SSA/P>=10mm and 1SSA/P-CD 
1 patient had 1 SSA/P>=10mm and 1 TSA 
1 patient had 1 SSA/P-CD and 1 TSA-CD 
1 patient had 3 SSA/Ps all greater than 10mm 
7 patients with distal ASL(s) 
(only distal lesions) 
3 patients with 1 SSA/P>=10mm each 
1 patient with 1 TSA-CD 
1 patient with 1 TSA 
1 patient with 1 SSA/P-CD>=10mm 
1 patient with 2 TSA-CDs 
ASL – Advanced serrated lesion 
HP – Hyperplastic polyp 
SSA/P – Sessile serrated adenoma/polyp 
SSA/P-CD – Sessile serrated adenoma/polyp with cytological dysplasia 
TSA – Traditional serrated adenoma 
TSA-CD – Traditional serrated adenoma with cytological dysplasia 
 
 
 
 
 
 
 
 
16 
 
Table 3 Odds of proximal advanced conventional neoplasia and proximal advanced 
serrated lesions based on distal findings† 
 
† 1 patient with synchronous proximal ACN and proximal ASL excluded 
* OR adjusted for age and sex, group with no neoplasia is the reference group 
ACN – Advanced conventional neoplasia 
ASL – Advanced serrated lesion 
HP – Hyperplastic polyp 
SSA/P – Sessile serrated adenoma/polyp 
 
 
 
 
 
 
 
 
 
 
 
Risk factor N proximal  
ACN,  
N (%) 
OR (95% CI)* p-
value  
proximal  
ASL, 
N (%) 
OR (95% CI)* p-
value  
Distal colon finding 
     No polyps 
     HP  
    SSA/P < 10mm with or without HP 
    Non-advanced adenoma with or 
without non-advanced serrated 
lesions (SSA/p+HP) 
     ASL 
     ACN  
 
1134 
330 
16 
 
 
362 
7 
60 
 
40(3.5) 
5 (1.5) 
0 
 
 
33(9.1) 
2 (28.6) 
18 (30) 
 
1 (reference) 
0.44 (0.17-1.13) 
- 
 
 
2.38 (1.46-3.87) 
10.22 (1.85-56.57) 
12.18 (6.33-23.43) 
 
 
0.09 
1.0 
 
 
<0.01 
<0.01 
<0.01 
 
27 (2.4) 
9 (2.7) 
1 (6.3) 
 
 
11 (3) 
1 (14.3) 
2 (3.3) 
 
1 (reference) 
1.18 (0.55-2.54) 
2.95 (0.37-23.34) 
 
 
1.28 (0.62-2.62) 
7.45 (0.83-66.69) 
1.43 (0.33-6.2) 
 
 
0.67 
0.31 
 
 
0.5 
0.07 
0.63 
Age 1.07 (1.04-1.09) <0.01 - 1.04 (1.01-1.07) 0.03 
Male sex 1.47 (0.95-2.25) 0.08 - 0.6 (0.33-1.08) 0.09 
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Table 4 Odds of proximal sessile serrated adenoma/polyps based on distal findings 
 
* OR adjusted for age and sex, group with no neoplasia is the reference group 
ACN – Advanced conventional neoplasia 
ASL – Advanced serrated lesion 
HP – Hyperplastic polyp 
SSA/P – Sessile serrated adenoma/polyp 
 
 
 
 
 
 
 
 
 
 
Risk factor N Any proximal  
SSA/P, N (%) 
OR (95% CI)* p-value  
Distal colon finding 
      No polyps 
      HP  
     SSA/P<10mm with or without HP                           
      Non-advanced adenoma with or without non-advanced 
serrated lesions (SSA/P+HP) 
      ASL 
      ACN 
 
1134 
330 
16 
 
362 
7 
61 
 
75 (6.6) 
30 (9.1) 
4 (25) 
 
21 (5.8) 
1 (14.3) 
7 (11.5) 
 
1 (reference) 
1.42 (0.91-2.21) 
4.74 (1.5-15.05) 
 
0.87 (0.53-1.44) 
2.38 (0.28-20.08) 
1.83 (0.81-4.17) 
 
- 
0.12 
<0.01 
 
0.58 
0.43 
0.15 
Age 1 (0.98-1.03) 0.7 
Male sex 0.95 (0.67-1.34) 0.76 
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